NO
Noxopharm
NOX.AX·ASXSydney AUFounded 201515 employees
Micro CapbiotechPublicOncology
Platform: Veyonda Idronoxil
Market Cap
$0.02B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
1
Stock Price & Catalysts (NOX.AX)
Loading NOX.AX stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Tixacapivasertib | NOX-1145 | Approved | 1 | Tau | Heart FailureMG | ||
| NOX-4885 | NOX-4885 | NDA/BLA | 1 | MET | MDS |
SEC Filings & Financial Documents
SEC filings are not available for ASX-listed companies.
Noxopharm trades on ASX (AU). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (2)